Waystar unveils transformative generative AI innovation to help providers recover billions of dollars tied to 450 million annual denied claims
Rhea-AI Summary
Waystar (Nasdaq: WAY) has launched Waystar AltitudeAI™, featuring AltitudeCreate™, a groundbreaking generative AI technology designed to automate the appeal process for denied healthcare claims. The innovation aims to help providers recover substantial portions of payments from over 450 million annually denied claims.
The initiative addresses significant challenges in healthcare administration, where $350 billion is lost annually to administrative waste, and hospitals spend $20 billion yearly attempting to overturn denied claims. More than half of denied claims are ultimately overturned, but the process is traditionally time-consuming and error-prone.
Waystar's platform processes over five billion annual transactions for approximately 50% of patients nationwide. The company's AI capabilities are now unified under the Waystar AltitudeAI™ brand, focusing on improving healthcare payment efficiency and accuracy.
Positive
- Launch of innovative AI technology to automate and streamline denied claims appeals process
- Platform processes 5 billion annual transactions covering 50% of US patients
- Addresses a $350 billion market opportunity in administrative waste
- Targets recovery from 450 million annually denied claims
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, WAY declined 1.44%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Healthcare providers gain access to first-of-its-kind generative AI technology, leading to faster and more accurate payments
The
"More than half of denied claims ultimately get overturned, but the appeal process is time-consuming, complex, and error-prone for providers," said Matt Hawkins, Chief Executive Officer of Waystar. "Generative AI unlocks a new era of productivity and precision, transforming how the industry simplifies claims, appeals, and payment workflows. With Waystar's AI-powered software platform, providers of all sizes are better equipped to appeal denied claims with unprecedented efficiency, accuracy, and ease."
Waystar has a decade-long track record of deploying AI pervasively across its software platform to address administrative waste in healthcare. Building on this leadership position, Waystar now brings together its comprehensive AI capabilities under the Waystar AltitudeAI™ brand, enabling providers to achieve elevated productivity and precision in healthcare payments. Waystar AltitudeAI™ leverages insights from Waystar's extensive payments network, which facilitates over five billion annual transactions for approximately
Waystar will discuss its AI and innovation efforts in greater detail at the J.P. Morgan Healthcare Conference, where Matt Hawkins will present on January 13, 2025, at 11:15 a.m. PT.
About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the
Investor Contact
Sandy Draper
investors@waystar.com
Media Contact
Kristin Lee
kristin.lee@waystar.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-unveils-transformative-generative-ai-innovation-to-help-providers-recover-billions-of-dollars-tied-to-450-million-annual-denied-claims-302348765.html
SOURCE Waystar